Three- versus four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: A randomized controlled trial

Authors :: Gulick, Roy M.
Ribaudo, Heather J.
Shikuma, Cecilia M.
Lalama, Christina
Schackman, Bruce R.
Meyer, William A., III
Acosta, Edward P.
Schouten, Jeffrey
Squires, Kathleen E.
Pilcher, Christopher D.
Murphy, Robert L.
Koletar, Susan L.
Carlson, Margrit
Reichman, Richard C.
Bastow, Barbara
Klingman, Karin L.
Kuritzkes, Daniel R.
Source :: JAMA, The Journal of the American Medical Association. August 16, 2006, Vol. 296 Issue 7, p769, 13 p.
Publication Year :: 2006
Abstract: The safety/efficacy of 3-drug versus 4-drug regimens for initial treatment of HIV-1 infection are compared. It is demonstrated that there is no significant differences, over 3 years, in safety/efficacy between the 3-drug versus 4-drug antiretroviral regimens for the initial treatment of HIV-1 infection.

Subjects :: Antiviral agents -- Complications and side effects
Antiviral agents -- Research
HIV infection -- Drug therapy
Clinical trials

Tools